The m6A modification of LINC01133 suppresses ER+ breast cancer progression by modulating IGF2BP2 protein stability via a ubiquitination-dependent mechanism

BackgroundBreast cancer is characterized as highly heterogenous and is a representative model to understand how molecular features of tumor biology determine therapeutic strategy. LINC01133 exhibits opposing expressing patterns across different breast cancer subtypes, yet its roles and mechanisms in...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Mai-dong Li, Ben-jie Shan, Lei Wang, Shuang Gao, Li Hao, Hai-yang Yu, Yue-yin Pan
Aineistotyyppi: Artikkeli
Kieli:englanti
Julkaistu: Frontiers Media S.A. 2025-06-01
Sarja:Frontiers in Oncology
Aiheet:
Linkit:https://www.frontiersin.org/articles/10.3389/fonc.2025.1608574/full
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia